一个分离式终端曝光驱动的CRISPR-RCA自放大系统,用于超快的DNA检测
Yiyue Jiang1, Jie Wu1, Xiayu Xiang1
1Department of Clinical Laboratory Medicine, Nanjing Drum Tower Hospital Clinical College of Jiangsu University, Zhongshan Road 321, Nanjing, 210008, Jiangsu Province, China.
Biosensors & bioelectronics
|August 13, 2025
概括
一个新的基于CRISPR的系统,AURORA,提供了超快速和灵敏的麻疹病毒 (MPXV) 检测. 这种创新方法克服了酶竞争,以快速地在现场诊断传染病.
科学领域:
- 分子生物学分子生物学
- 生物技术是生物技术.
- 传染病诊断 传染病诊断 传染病诊断
背景情况:
- 与异热放大相结合的CRISPR-Cas系统在现场检测传染病方面比qPCR具有优势.
- 卡斯蛋白和放大酶之间的酶竞争限制了目前基于CRISPR的方法中的信号放大.
研究的目的:
- 开发一种新型的单管自放大系统 (AURORA),用于超快速和灵敏地检测麻疹病毒 (MPXV).
- 为了克服Cas12a和phi29DNA聚合酶之间的基质竞争,以增强信号放大.
主要方法:
- 开发了一种双功能探头 (DF探头) 和一个CRISPR-Cas12a/滚动圈放大 (RCA) 系统 (AURORA).
- 利用Cas12a的跨裂变活动来暴露DF探针的3'终端,通过phi29 DNA聚合酶启动目标原始的RCA.
- 设计了该系统,以防止在单个管内进行酶基质竞争.
主要成果:
- 在8分钟内实现了MPXV DNA的超快信号放大.
- 对MPXVDNA的检测极限 (LOD) 是88aM (53副本/μL).
- 在测试36个临床MPXV样本时,获得的结果与qPCR一致,样本到答案时间低至10分钟.
结论:
- 在AURORA系统提供超快速和精确的MPXV的检测.
- 这项技术为预防和控制严重传染病提供了更有效的工具.
- 光超越了现有的基于CRISPR的检测方法的局限性,提高了诊断能力.
相关概念视频
CRISPR
52.9K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.9K
CRISPR/Cas9 Genome Editing
220
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
220


